Outcomes of 23-Gauge Vitrectomy Combined with Phacoemulsification, Panretinal Photocoagulation, and Trabeculectomy without Use of Anti-VEGF Agents for Neovascular Glaucoma with Vitreous Hemorrhage

Table 1

Clinical data of patients with NVG.

Case number	Sex	Age (y)	Systemic disease	Diagnosis	Previous treatment	BCVA		IOP (mmHg)		Complications	Follow-up (months)
						Preop.	Postop.	Preop.	Postop.
1	M	76	Hypertension	CRVO	B + C	0.02	0.08	58	21	Fibrosis exudates in AC	16
2	M	61	DM + hypertension	CRVO	B + C, partial laser	0.04	0.04	53	22	None	17
3	F	58	DM + RF	PDR + BRVO	B + C	LP	0.02	60	30	Fibrosis exudates in AC	12
4	F	62	DM + hypertension	CRVO	B + C, partial laser	HM	0.04	58	20	None	15
5	M	59	DM + RF	PDR + BRVO	B + C	CF	0.04	59	18	Temporary IOP elevation	14
6	F	61	DM + RF	PDR	B + C	0.08	0.1	48	17	None	17
7	M	63	DM + hypertension	CRVO	B + C	0.06	0.1	61	19	Fibrosis exudates in AC	12
8	M	63	DM + RF	PDR	B + C, partial laser	0.1	0.3	40	15	Fibrosis exudates in AC	13
9	F	59	DM + RF	PDR + BRVO	B + C	0.08	0.08	39	16	None	12
10	M	58	DM + hypertension	CRVO	B + C, partial laser	0.04	0.06	56	21	Fibrosis exudates in AC	12
11	F	60	DM + hypertension	PDR + BRVO	B + C	HM	0.02	58	19	SCH	24
12	F	63	DM + hypertension	PDR + BRVO	B + C	HM	0.08	57	18	None	13
13	M	59	DM + RF	PDR	B + C, partial laser	0.02	0.02	56	20	Fibrosis exudates in AC	17
14	M	71	Hypertension	CRVO	B + C	0.02	0.04	54	18	Fibrosis exudates in AC	12
15	F	63	DM + RF	PDR + BRVO	B + C	LP	0.04	64	19	Temporary IOP elevation	16
16	M	58	DM + hypertension	CRVO	B + C	CF	0.06	55	17	None	14
17	M	63	DM + RF	PDR	B + C	0.04	0.04	54	18	None	13
18	F	65	Hypertension	CRVO	B + C, partial laser	0.2	0.4	38	10	None	13

F = female; M = male; DM = diabetes mellitus; RF = renal failure; BCVA = best corrected visual acuity; AC = anterior chamber; SCH = suprachoroidal hemorrhage; B = brinzolamide; C = 2% carteolol hydrochloride.